Top compounds associated with response to CTD-2006C1.13


Feature Type Standardized
Nominal ANOVA
mRNA momelotinib CTRPv2 pan-cancer AAC 0.071 0.06
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.058 0.07
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.073 0.07
mRNA pac-1 CTRPv2 pan-cancer AAC 0.072 0.07
mRNA paclitaxel CTRPv2 pan-cancer AAC 0.066 0.07
mRNA staurosporine CTRPv2 pan-cancer AAC 0.14 0.07
mRNA Bosutinib CTRPv2 pan-cancer AAC 0.069 0.07
mRNA spautin-1 CTRPv2 pan-cancer AAC -0.074 0.07
mRNA GDC-0879 CTRPv2 pan-cancer AAC -0.07 0.07
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.069 0.07
Download CSV